Skip to main content
[Preprint]. 2020 Jun 2:2020.05.28.20105692. [Version 1] doi: 10.1101/2020.05.28.20105692

Figure 3. NAbs reactivity in convalescent COVID-19 and control sera with other infection by neutralization PCR assay.

Figure 3.

Convalescent COVID-19 sera (N=18) were from patients 14 days after symptom onset (blue), and control sera (N=43) from patients with HCV, flavivirus infection and Lyme disease (red).